Skip to main content
. 2015 Mar 27;11(3):e1004998. doi: 10.1371/journal.pgen.1004998

Table 1. Human CNVs, candidate (bold) and control genes, and their respective Drosophila orthologues.

CNV Identity Chr Start End CNV Type Human Candidate genes Drosophila Orthologues of candidate genes Figure
11079_chr3_loss_197208363_l 3 197208363 198838422 Loss Phosphate Cytidylyltransferase 1, Choline, Alpha (PCYT1A) fsn 3
Discs large 1 (DLG1) Discs large (dlg) 3
p21-activated kinase 2 (PAK2) p21-activated kinases (Pak) 3
LOC220729 CG5359 3
12289_chr5_loss_11403621_l 5 11403621 11493124 Loss catenin delta 2 (CTNND2) p10 catenin (p120ctn) 2
1946_301_chr9_gain_138505259 9 138505259 139336068 Gain Notch1 Notch (N) 2
12235_chr9_gain_129907917_l 9 129907917 130512360 Gain Dynamin-1 (DNM1) dynamin/shibire (shib) 5
Prostaglandin E Synthase 2 (PTGES2) su(p) 5
SWI5 Recombination Repair Homolog (SWI5) CG14104 5
alpha-Spectrin (SPTAN1) alpha-Spectrin (a-spec) 5
12239_chr22_loss_17249508_l 22 17249508 18693261 Loss T-box 1 (TBX1) optomotor-blind-related-gene-1 (orbg-1) 4
Guanine nucleotide-binding protein subunit beta-like protein 1 (GNB1L) CG13192 4
histone cell cycle regulator (HIRA) hira 4
solute carrier family 25 (SLC25A1) sea 4
Zinc finger, DHHC-type containing 8 (ZDHHC8) CG34449 4
George syndrome critical region gene 8 (DGCR8) partner of drosha (pasha) 4
Septin 5 (SEPT5) Septin 4 (Sept4) 4
12691.p1_chr16_loss_68529466_s 16 68529466  71494580 Loss VAC14 CG5608 S1
PH domain and leucine rich repeat protein phosphatase-like (PHLPPL) PH domain leucine-rich repeat protein phosphatase S1
Splicing factor 3B subunit 3 (SF3B3) CG13900 S1
Calbindin 2 (CALB2) Calbindin 53E (cbn) S1
tyrosine aminotransferase (TAT) CG5608 S1
C-type lectin domain family 18, member C (CLEC18C) CG3626 S1
AP1G1 adaptor-related protein complex 1, gamma 1 subunit (AP1G1) AP-1γ S1
Dihydroorotate dehydrogenase (DHODH) Dihydroorotate dehydrogenase (dhod) S1

CNVs were selected from previous studies that identified de novo or rare CNVs in the genomes of individuals with ASD (see Methods). CNVs post-fixed “_1” were taken from the study by Levy et al. [28], CNVs post-fixed “_s” were taken from the study by Sanders et al.[29], while the CNV 1946_301_chr9_gain_138505259 was taken from the AGP study [5]. The candidate and control genes were among those genes affected by the given CNV: The protein products of the candidate genes interacted in a previously identified network of interacting proteins associated with neural functioning, while the control genes’ protein products are expressed embryonically and neuronally.